Development of Anti-Virulence Therapeutics against Mono-ADP-Ribosyltransferase Toxins
Open Access
Abstract
Mono-ADP-ribosyltransferase toxins are often key virulence factors produced by pathogenic bacteria as tools to compromise the target host cell. These toxins are enzymes that use host cellular NAD+ as the substrate to modify a critical macromolecule target in the host cell machinery. This post-translational modification of the target macromolecule (usually protein or DNA) acts like a switch to turn the target activity on or off resulting in impairment of a critical process or pathway in the host. One approach to stymie bacterial pathogens is to curtail the toxic action of these factors by designing small molecules that bind tightly to the enzyme active site and prevent catalytic function. The inactivation of these toxins/enzymes is targeted for the site of action within the host cell and small molecule therapeutics can function as anti-virulence agents by disarming the pathogen. This represents an alternative strategy to antibiotic therapy with the potential as a paradigm shift that may circumvent multi-drug resistance in the offending microbe. In this review, work that has been accomplished during the past two decades on this approach to develop anti-virulence compounds against mono-ADP-ribosyltransferase toxins will be discussed.Keywords
Funding Information
- Natural Sciences and Engineering Research Council of Canada (Discovery grant (#105440); Strategic grant (#494213))
This publication has 93 references indexed in Scilit:
- Identification and characterization of two novel toxins expressed by the lethal honey bee pathogen P aenibacillus larvae, the causative agent of A merican foulbroodEnvironmental Microbiology, 2013
- Certhrax Toxin, an Anthrax-related ADP-ribosyltransferase from Bacillus cereusJournal of Biological Chemistry, 2012
- The 1.8 Å Cholix Toxin Crystal Structure in Complex with NAD+ and Evidence for a New Kinetic ModelJournal of Biological Chemistry, 2012
- Newly Discovered and Characterized Antivirulence Compounds Inhibit Bacterial Mono-ADP-Ribosyltransferase ToxinsAntimicrobial Agents and Chemotherapy, 2011
- Cholera- and Anthrax-Like Toxins Are among Several New ADP-RibosyltransferasesPLOS Computational Biology, 2010
- Pseudomonas exotoxin kills Drosophila S2 cells via apoptosisToxicon, 2010
- Pseudomonas Exotoxin A-Mediated Apoptosis Is Bak Dependent and Preceded by the Degradation of Mcl-1Molecular and Cellular Biology, 2010
- Photox, a Novel Actin-targeting Mono-ADP-ribosyltransferase from Photorhabdus luminescensJournal of Biological Chemistry, 2010
- The nature and character of the transition state for the ADP‐ribosyltransferase reactionEMBO Reports, 2008
- Identification of Small Molecule Inhibitors of Pseudomonas aeruginosa Exoenzyme S Using a Yeast Phenotypic ScreenPLOS Genetics, 2008